Tamoxifen News and Research

RSS
Tamoxifen is a drug used to treat certain types of breast cancer in women and men. It is also used to prevent breast cancer in women who have had ductal carcinoma in situ (abnormal cells in the ducts of the breast) and in women who are at a high risk of developing breast cancer. Tamoxifen is also being studied in the treatment of other types of cancer. It blocks the effects of the hormone estrogen in the breast. Tamoxifen is a type of antiestrogen. Also called tamoxifen citrate.
Targeted breast cancer therapy shows 'encouraging' results

Targeted breast cancer therapy shows 'encouraging' results

Targeted therapy plus hormone therapy improves survival in premenopausal patients with advanced HR+ breast cancer

Targeted therapy plus hormone therapy improves survival in premenopausal patients with advanced HR+ breast cancer

Researchers unveil clues into how breast cancer cells spread around the body

Researchers unveil clues into how breast cancer cells spread around the body

Combination of radiotherapy and anti-hormone treatment can prevent recurrence of hormone-driven breast cancer

Combination of radiotherapy and anti-hormone treatment can prevent recurrence of hormone-driven breast cancer

Partner status influences link between sexual problems and self-efficacy in breast cancer survivors

Partner status influences link between sexual problems and self-efficacy in breast cancer survivors

Molecular patterns could help predict relapse risk in breast cancer patients

Molecular patterns could help predict relapse risk in breast cancer patients

Estrogen can affect surrounding brain cells to promote triple-negative breast cancer metastasis

Estrogen can affect surrounding brain cells to promote triple-negative breast cancer metastasis

Researchers unravel path of metallodrug in a breast cancer cell

Researchers unravel path of metallodrug in a breast cancer cell

Scientists create comprehensive new method to predict breast cancer risk

Scientists create comprehensive new method to predict breast cancer risk

MUSC researchers link higher levels of AGEs to ER-positive breast cancer risk

MUSC researchers link higher levels of AGEs to ER-positive breast cancer risk

New substance could improve efficacy of established breast cancer treatments

New substance could improve efficacy of established breast cancer treatments

Study: Drug reduces hot flash frequency, improves quality of life in breast cancer survivors

Study: Drug reduces hot flash frequency, improves quality of life in breast cancer survivors

Women consider potential harms and benefits of using preventive therapy for breast cancer

Women consider potential harms and benefits of using preventive therapy for breast cancer

Researchers identify molecule to fight myotubular myopathy

Researchers identify molecule to fight myotubular myopathy

New model of FSHD could be useful to study effectiveness of experimental therapeutics

New model of FSHD could be useful to study effectiveness of experimental therapeutics

Radiation therapy can lower risk of breast cancer recurrence in patients with ‘good risk’ DCIS

Radiation therapy can lower risk of breast cancer recurrence in patients with ‘good risk’ DCIS

Drugs approved for breast cancer treatment are effective and well tolerated in men

Drugs approved for breast cancer treatment are effective and well tolerated in men

Phase III trial reports positive results with HDAC inhibitor in advanced breast cancer patients

Phase III trial reports positive results with HDAC inhibitor in advanced breast cancer patients

Zoledronic acid increases disease-free survival in premenopausal women with HR+ early breast cancer

Zoledronic acid increases disease-free survival in premenopausal women with HR+ early breast cancer

High rate of non-adherence to hormonal therapy found among premenopausal early breast cancer patients

High rate of non-adherence to hormonal therapy found among premenopausal early breast cancer patients